Market Overview

The Global Non-Hodgkin Lymphoma Therapeutics Market was valued at USD 9,932.6 million in 2023 and is expected to reach USD 18,797.1 million by 2031 while growing at a CAGR of 8.3% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global non-hodgkin lymphoma therapeutics market growth. Non-Hodgkin lymphoma (NHL) therapeutics encompass the diverse treatment modalities for addressing this cancer type, originating in the lymphatic system. The treatment strategies for non-Hodgkin lymphoma are tailored based on the subtype, disease stage, and individual patient considerations.

The increasing incidence and prevalence, coupled with ongoing research and development efforts leading to the discovery of new treatment modalities such as targeted therapies, immunotherapies, and combination regimens, drive the non-Hodgkin lymphoma (NHL) therapeutics market. However, the market's growth is hindered by the high cost of treatment and concerns regarding safety and tolerability.

Furthermore, the global non-hodgkin lymphoma therapeutics industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Type Analysis

The Global Non-Hodgkin Lymphoma Therapeutics Market is segmented among Leukemia, Lymphoma, Multiple Myeloma, and Others, based on Type. In 2023, Leukemia accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Therapy Analysis

The Global Non-Hodgkin Lymphoma Therapeutics Market is segmented among Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others, based on Therapy. In 2023, Radiotherapy accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Non-Hodgkin Lymphoma Therapeutics Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Pfizer Inc, F. Hoffmann-LA Roche Ltd, Sanofi, Bristol-Myers Squibb Company, AbbVie Inc, Novartis AG, GlaxoSmithKline PLC, Celgene Corporation, Johnson & Johnson Services, Inc, and Takeda Pharmaceutical Company.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Non-Hodgkin Lymphoma Therapeutics Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Non-Hodgkin Lymphoma Therapeutics Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Non-Hodgkin Lymphoma Therapeutics Market Segmentation, By Type

• Global Non-Hodgkin Lymphoma Therapeutics Market Share Analysis, By Type

• Global Non-Hodgkin Lymphoma Therapeutics Market Growth Analysis, By Type

• Global Non-Hodgkin Lymphoma Therapeutics Market Trends, By Type

o Leukemia

Ø Acute Lymphocytic Leukemia

Ø Chronic Lymphocytic Leukemia

Ø Acute Myeloid Leukemia

Ø Chronic Myeloid Leukemia

o Lymphoma

o Multiple Myeloma

o Others

6. Global Non-Hodgkin Lymphoma Therapeutics Market Segmentation, By Therapy

• Global Non-Hodgkin Lymphoma Therapeutics Market Share Analysis, By Therapy

• Global Non-Hodgkin Lymphoma Therapeutics Market Growth Analysis, By Therapy

• Global Non-Hodgkin Lymphoma Therapeutics Market Trends, By Therapy

o Chemotherapy

o Radiotherapy

o Immunotherapy

o Stem Cell Transplantation

o Others

7. Global Non-Hodgkin Lymphoma Therapeutics Market Segmentation, By Region

• Global Non-Hodgkin Lymphoma Therapeutics Market Share Analysis, By Region

• Global Non-Hodgkin Lymphoma Therapeutics Market Growth Analysis, By Region

• Global Non-Hodgkin Lymphoma Therapeutics Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Pfizer Inc*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• F. Hoffmann-LA Roche Ltd

• Sanofi

• Bristol-Myers Squibb Company

• AbbVie Inc

• Novartis AG

• GlaxoSmithKline PLC

• Celgene Corporation

• Johnson & Johnson Services, Inc

• Takeda Pharmaceutical Company

*Similar analysis will be provided for each company listed above.